- Author
-
S.C. Braam
- Title
- Fertility treatment in women with WHO type II ovulation disorder
- Supervisors
-
B.W.J. Mol
- Co-supervisors
-
M. van Wely
J.P. de Bruin - Award date
- 3 July 2020
- Number of pages
- 203
- ISBN
- 9789463759373
- Document type
- PhD thesis
- Faculty
- Faculty of Medicine (AMC-UvA)
- Abstract
-
Infertility affects about 10 to 15 percent of all couples that are trying to conceive. One of the main diagnoses of infertility is ovulation disorders. The World Health Organization (WHO) categorizes ovulation disorders in type I, II and III. WHO type I ovulation disorders are caused by hypothalamic pituitary failure. Type II ovulation disorders are defined as dysfunctions of the hypothalamic-pituitary-ovarian axis and includes polycystic ovary syndrome (PCOS). Type III ovulation disorders are caused by ovarian failure.
This thesis describes studies based on cohort and cross-sectional studies that have included women with WHO type II ovulation disorder, the largest group of women. At this time clomiphene citrate (CC) was the preferred first-line treatment for ovulation induction in women with WHO II ovulation disorder. Most guidelines nowadays advise to use letrozole as it is more effective and seems to result in less multiple pregnancies, but as letrozole is off-label for this indication, CC is still commonly used as first-line treatment. Women that do not ovulate on CC can undergo ovulation induction with letrozole, gonadotropins or laparoscopic ovarian drilling before moving on to IVF. Ovarian hyperstimulation syndrome (OHSS) is a complication of IVF. Women with high antral follicle counts (AFC), such as in women with PCOS, are at increased risk of developing OHSS. In vitro maturation (IVM) is an alternative treatment for IVF that is offered to prevent OHSS.
In this thesis we evaluated the effectiveness, safety and associated costs of the different treatment options, with special focus on the prevention of OHSS. - Persistent Identifier
- https://hdl.handle.net/11245.1/d0528abc-f985-4135-b5af-b697e83743e7
- Downloads
-
Thesis (complete)
Front matter
Chapter 1: General introduction and outline of the thesis
Chapter 2: Treatment strategies and cumulative live birth rates in WHO-II ovulation disorders
Chapter 3: What is the value of monitoring by ultrasonography in ovulation induction with clomiphene citrate?
Chapter 4: How long should we continue clomiphene citrate in anovulatory women?
Chapter 5: In vitro maturation of oocytes in women at risk of ovarian hyperstimulation syndrome: a prospective multicenter cohort study
Chapter 6: Spontaneous pregnancies after in vitro maturation treatment in two polycystic ovary syndrome patients
Chapter 7: The effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilization in women with a high antral follicle count
Chapter 8: In vitro maturation versus in vitro fertilization in women with a high antral follicle count: a cost-effectiveness analysis
Chapter 9: The perspective of women with an increased risk of OHSS regarding the safety and burden of IVF: a discrete choice experiment
Chapter 10: Summary and implications for practice and future research
Chapter 11: Nederlandse samenvatting en implicaties voor de klinische praktijk en toekomstig onderzoek
List of co-authors and affiliations; Author contributions; PhD portfolio; List of publications; Dankwoord; About the author
Stellingen
Disclaimer/Complaints regulations
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library, or send a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.